Psilocybin, MDMA, and Covid-19 sequelae

The Covid-19 pandemic changed the psychological trends of 2021 rapidly. Years that otherwise focused on treatment with psilocybin and MDMA looked at the potential for lasting cognitive effects of Covid-19 and the surprising increase in the number of healthcare professionals meeting diagnostic criteria. It has changed in the year. For PTSD.

Psilocybin supportive care to treat depression

Psilocybin, known as the “magic mushroom,” is being considered in combination with treatments to treat major depressive disorders. A Survey Johns Hopkins Medicine found that two doses of psilocybin in combination with treatment rapidly and significantly reduced the symptoms of depression in most studies. Half of the study participants continued to reduce their symptoms throughout the 4-week follow-up period.Oregon has recently become the first state Legalization Psilocybin for use in the treatment setting.

MDMA supportive therapy to treat PTSD

The drug 3,4-methylenedioxymethamphetamine (MDMA) has been shown to be effective when used in combination with treatments to treat post-traumatic stress disorders. Treatment is in the setting of an outpatient with a place of residence.Currently there is Phase III trial This means that the FDA has determined that MDMA will treat serious or life-threatening conditions, and preliminary evidence indicates that MDMA can cause significant improvement. Other approved treatments for PTSD.

When prescribing MDMA supportive care to treat PTSD, Savings $ 103.2 million in 30 years. MDMA supportive care adds a total of 918 quality-adjusted life years (QALYs) for every 1,000 people treated. QALY is an estimate of how much quality of life a person can get as a result of treatment.

< position="inread" progressive="" ad-id="article-0-inread" aria-hidden="true" role="presentation"/>

Increasing cases of PTSD in healthcare professionals

The Covid-19 pandemic has pushed millions of healthcare professionals to the limit, including inaccessibility of personal protective equipment (PPE).Healthcare Professional Burnout And Suicide Rate Already Best Of all professions. In 2021, treating patients with Covid-19 is expected to increase the number of healthcare professionals who meet the diagnostic criteria for post-traumatic stress disorder (PTSD).

Isolation tends to cause more serious symptoms of PTSD. Many medical professionals were the only witnesses to the patient’s death, including the patient’s final call to say goodbye to the family. Some medical professionals report being verbally abused by Covid-19 patients. This is in addition to the fact that medical staff are isolated from friends and family, and some medical professionals live elsewhere. garage To prevent virus infection. A related issue is the availability of funding to treat cases of PTSD surges.

According to a survey conducted between March and April 2020 Norway, 28% of healthcare professionals treating Covid-19 met the diagnostic criteria for PTSD. We are now seven months away, and the longer we are exposed to post-traumatic stress, the greater our chances of developing PTSD.

Prolonged cognitive effect of Covid-19

You may be classified as recovering from Covid-19, but your cognitive function may still be impaired. Covid-19 survivors are known to have executive function problems in the brain performance, Probably related to the inflammatory process of the body. The hippocampus of the brain has also been found to appear to be particularly vulnerable to the effects of Covid-19.this Vulnerability It can cause accelerated neurodegenerative diseases such as memory loss and Alzheimer’s disease.

There is also an additional cognitive effect for those who did not get Covid-19.Those who have already been diagnosed dementia The rate of depression, anxiety, stress and aggression is increasing. This is due to the fundamental changes that have occurred since Covid-19, such as quarantine, new standard operating procedures, and inability to see family members.